Natural Product: NPC521353

Natural Product IDNPC521353
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
8-[5-(5,7-dihydroxy-4-oxo-chromen-2-yl)-2-hydroxy-phenyl]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one
IUPAC Name 8-[5-(5,7-dihydroxy-4-oxo-chromen-2-yl)-2-hydroxy-phenyl]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey TWWVGBFACRJZQC-UHFFFAOYSA-N
Standard InCHI InChI=1S/C30H18O11/c31-14-7-19(35)28-22(38)10-24(40-26(28)8-14)12-1-3-16(32)15(5-12)27-20(36)9-21(37)29-23(39)11-25(41-30(27)29)13-2-4-17(33)18(34)6-13/h1-11,31-37H
SMILES O=C1C=C(C2=CC=C(O)C(C3=C(O)C=C(O)C4=C3OC(C3=CC=C(O)C(O)=C3)=CC4=O)=C2)OC2=CC(O)=CC(O)=C12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   554.08 Volume:   530.606
?
Van der Waals volume.
Dense:   1.044 LogP:   4.123
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.487
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.203
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   36.0
TPSA:   202.03
?
Topological Polar Surface Area.
H-Bond Acceptor:   11.0
H-Bond Donor:   7.0 Rings:   6.0
Heavy Atoms:   11.0

MedChem Properties

QED Drug-Likeness Score:   0.148 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.139 Fsp3:   0.0
MCE-18:   37.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.996 Fluc inhibitor:   0.606
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.988
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.975
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.65 Promiscuous compounds:   0.915

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.617 MDCK Permeability:   -4.823
Pgp-inhibitor:   0.0 Pgp-substrate:   0.402
PAMPA:   0.476
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.942 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.952
Plasma Protein Binding (PPB):   97.122% Volume Distribution (VD):   -0.525
Fu: 2.012%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.898
OATP1B3 inhibitor:   0.992 BCRP inhibitor:   0.985
BSEP inhibitor:   0.514

ADMET: Metabolism

CYP1A2-inhibitor:   0.318 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.021 CYP2C9-substrate:   0.638
CYP2D6-inhibitor:   0.998 CYP2D6-substrate:   1.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.168
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.959
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.905 Half-life (T1/2):  2.222

ADMET: Toxicity

hERG Blockers:  0.031 hERG Blockers (10um):  0.541
Human Hepatotoxicity (H-HT):  0.387 Drug-induced Liver Injury (DILI):  0.985
AMES Toxicity:  0.812 Rat Oral Acute Toxicity:  0.666
Maximum Recommended Daily Dose:  0.987 Skin Sensitization:  0.908
Carcinogencity:  0.763 Eye Corrosion:  0.002
Eye Irritation:  0.997 Respiratory Toxicity:  0.886
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.092
Hematotoxicity:  0.01 Drug-induced Nephrotoxicity:  0.004
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.069
A549 Cytotoxicity:  0.938 Hek293 Cytotoxicity:  0.959
BCF:   1.113
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.359
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.799
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.541
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13468 Cryptomeria japonica Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO13468 Cryptomeria japonica Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO13468 Cryptomeria japonica Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC521353 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8689 High Similarity NPC610480
0.8644 High Similarity NPC138299
0.7612 Intermediate Similarity NPC303485
0.75 Intermediate Similarity NPC279121
0.7164 Intermediate Similarity NPC259757
0.6765 Remote Similarity NPC603692
0.6618 Remote Similarity NPC254351
0.6528 Remote Similarity NPC194593
0.6418 Remote Similarity NPC111112
0.6389 Remote Similarity NPC290830
0.6389 Remote Similarity NPC71061
0.6324 Remote Similarity NPC291746
0.6271 Remote Similarity NPC50898
0.6216 Remote Similarity NPC121649
0.6167 Remote Similarity NPC222713
0.6167 Remote Similarity NPC175013
0.6133 Remote Similarity NPC601565
0.6087 Remote Similarity NPC288840
0.6027 Remote Similarity NPC150908
0.597 Remote Similarity NPC67322
0.5811 Remote Similarity NPC600972
0.5738 Remote Similarity NPC78540
0.5625 Remote Similarity NPC610974
0.5588 Remote Similarity NPC183950
0.5556 Remote Similarity NPC274121
0.5469 Remote Similarity NPC213216
0.5441 Remote Similarity NPC52005
0.5397 Remote Similarity NPC275772
0.5397 Remote Similarity NPC20791
0.5385 Remote Similarity NPC215203
0.5333 Remote Similarity NPC606549
0.5312 Remote Similarity NPC179271
0.525 Remote Similarity NPC265624
0.5238 Remote Similarity NPC17286
0.5224 Remote Similarity NPC231772
0.5224 Remote Similarity NPC601901
0.5217 Remote Similarity NPC12200
0.5205 Remote Similarity NPC112954
0.5156 Remote Similarity NPC70136
0.5128 Remote Similarity NPC72425
0.5075 Remote Similarity NPC605617
0.5063 Remote Similarity NPC186227

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC521353 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.75 Intermediate Similarity NPD1511 Phase 2
0.5397 Remote Similarity NPD1512 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data